Articles

Researchers looking at over 100,000 pregnancies find that gestational diabetes is one of the greatest risks for delivering a large-for-gestational age baby….

A new report reviewing the impact of hypoglycemia on patients with diabetes will also provide guidance about how this new information should be incorporated into clinical practice….

A six year study looked into drug eluting stents in diabetic patients and the risk of thrombosis….

Five studies show positive results for new GLP-1 drug dulaglutide…. Eli Lilly and Company announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes. Primary efficacy endpoints of …

Protein that lowers blood sugar may be new oral diabetic agent for type 1 patients…. Note: The following article was adapted from an original article, Insulin’s Little Helper: A New Pill for Type 1 Diabetes?, published on the Diabetes Mine site, April 10, 2013. SOGA, a protein that lowers blood glucose, …

Possible use of co-enzyme 10 to reduce this risk is being considered….

Randomized control trial looked at patients with gestational diabetes who followed a low carb diet and those who ate a normal diet, comparing the need for insulin….

Significant dose-response effect seen in normoglycemic adults, with no GI side effects….

Research finds that there is a U-shaped correlation between BMI at time of type 2 diagnosis….

Research shows a 65% increase for development of type 2 diabetes for young adults with high levels of mercury exposure….